Article in Journal of gastrointestinal and liver diseases : JGLD, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
David YardeniDepartment of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer-Sheva, Israel. yardeda@gmail.com.
Vitali DizengofDepartment of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer-Sheva, Israel. vitalydoc@gmail.com.
Anat Nevo-ShorDepartment of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer-Sheva, Israel. anatnev@gmail.com.
Naim AbufrehaDepartment of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer-Sheva, Israel. abufreha@yahoo.de.
Harel DahariThe Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood IL, United States. hdahari@luc.edu.
Ohad EtzionDepartment of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer-Sheva, Israel. ohadet34@yahoo.com.
Funding
Collaborative Integration of HCV Molecular Virology and Mathematical ModelingR01AI078881 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PERELSON, ALAN S, UPRICHARD, SUSAN L. · 2011 to 2025
$7.5M
Computational discovery of effective hepatitis C intervention strategiesR01GM121600 · NIGMS · LOYOLA UNIVERSITY CHICAGO · PI BOODRAM, BASMATTEE, DAHARI, HAREL · 2017 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection. · full record | OpenQuestion